S&W Corporation (KOSDAQ:103230)

Ligand Pharmaceuticals Revenue

S&W Corporation had revenue of 12.54B KRW in the quarter ending March 31, 2025, with 17.31% growth. This brings the company's revenue in the last twelve months to 48.98B, up 12.98% year-over-year. In the year 2024, S&W Corporation had annual revenue of 47.13B with 8.01% growth.

• Revenue (ttm): 48.98B
• Revenue Growth: +12.98%
• P/S Ratio: 0.60
• Revenue / Employee: 215.77M
• Employees: 227
• Market Cap: 29.52B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.13B	3.50B	8.01%
Dec 31, 2023	43.63B	7.62B	21.15%
Dec 31, 2022	36.02B	6.05B	20.20%
Dec 31, 2021	29.96B	-3.53B	-10.55%
Dec 31, 2020	33.50B	-2.53B	-7.02%